Abstract
Mesoporous silica nanoparticles (MSNs) have gained huge attention among scientific groups by virtue of its distinct features. The monodispersity nature, tunable pore size, and surface engineering made it versatile nanocarriers in the field of pharmaceutical sciences and biomedical arena. MSNs have been exploited in bio-imaging by means of its greater stability and inherent photoluminescence features. Apart from bio-imaging, smart stimuli-responsive nanomaterials have been explored in the management of several devastating diseases specifically cancers and neurological disorders. The applicability of surface-modified MSNs provides the site-specific targeting while reducing the off-target noxious effects. The current chapter majorly covers the MSN-mediated nanotechnological approaches to showcase the significant theranostic applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 5-FU:
-
5-Fluorouracil
- AMF:
-
Alternating magnetic field
- APTES:
-
(3-Aminopropyl) triethoxysilane
- ATO:
-
Arsenic trioxide
- ATP:
-
Adenosine tri-phosphate
- CAP:
-
Capecitabine
- CMC:
-
Critical micelle concentration
- CTAB:
-
Cetyl trimethyl ammonium bromide
- DDS:
-
Drug delivery systems
- DNA:
-
Deoxyribonucleic acid
- DOX:
-
Doxorubicin
- EphA2:
-
Ephrin type-A receptor 2
- EPR:
-
Enhanced permeability and retention
- FA:
-
Folic acid
- GEM:
-
Gemcitabine
- HCC:
-
Hepatocellular cancer
- LCST:
-
Lower critical solution temperature
- MDR:
-
Multidrug resistance
- MSNs:
-
Mesoporous silica nanoparticles
- NIR:
-
Near infrared
- O/W:
-
Oil in water
- ORMOSIL:
-
Organically modified silica
- PLAA:
-
Phospholipase A2 activating protein
- PMO:
-
Periodic mesoporous organosilica
- PNIPAM:
-
Poly(N-isopropylacrylamide)
- PSMA:
-
Anti-prostrate-specific membrane antigen
- RNA:
-
Ribonucleic acid
- ROS:
-
Reactive oxygen species
- SBA:
-
Santa Barbara Amorphous
- TAT:
-
Trans-activator of transcription
- TEOS:
-
Tetraethyl orthosilicate
References
Abukhadra MR, Refay NM, El-Sherbeeny AM, El-Meligy MA (2020) Insight into the loading and release properties of MCM-48/biopolymer composites as carriers for 5-fluorouracil: equilibrium modeling and pharmacokinetic studies. ACS omega 20:11745–11755
Antonietti M, Berton B, Göltner C, Hentze HP (1998) Synthesis of mesoporous silica with large pores and bimodal pore size distribution by templating of polymer latices. Adv Mater 2:154–159
Asefa T, MacLachlan MJ, Grondey H, Coombs N, Ozin GA (2000) Metamorphic channels in periodic mesoporous methylenesilica. Angew Chem Int Ed 10:1808–1811
Attard GS, Glyde JC, Göltner CG (1995) Liquid-crystalline phases as templates for the synthesis of mesoporous silica. Nature 6555:366–368
Bagshaw SA, Pinnavaia TJ (1996) Mesoporous alumina molecular sieves. Angew Chem Int Ed Engl 10:1102–1105
Barbe C, Bartlett J, Kong L, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G (2004) Silica particles: a novel drug-delivery system. Adv Mater 21:1959–1966
Beltrán-Osuna ÁA, Perilla JE (2016) Colloidal and spherical mesoporous silica particles: synthesis and new technologies for delivery applications. J Sol-Gel Sci Technol 2:480–496
Biswas N (2017) Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water-soluble valsartan. Eur J Pharm Sci 99:152–160
Caltagirone C, Bettoschi A, Garau A, Montis R (2015) Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents. Chem Soc Rev 14:4645–4671
Chang D, Gao Y, Wang L, Liu G, Chen Y, Wang T, Tao W, Mei L, Huang L, Zeng X (2016) Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy. J Colloid Interface Sci 463:279–287
Chen J, Qiu X, Ouyang J, Kong J, Zhong W, Xing MM (2011b) pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery. Biomacromolecules 10:3601–3611
Chen X, Xu C, He H (2019) Electrospinning of silica nanoparticles-entrapped nanofibers for sustained gentamicin release. Biochem Biophys Res Commun 4:1085–1089
Chen Y, Chen H, Guo L, He Q, Chen F, Zhou J, Feng J, Shi J (2010) Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 1:529–539
Chen Y, Chen H, Sun Y, Zheng Y, Zeng D, Li F, Zhang S, Wang X, Zhang K, Ma M, He Q (2011a) Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew Chem Int Ed 52:12505–12509
Chen Y, Yin Q, Ji X (2012) Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 33:7126–7137
Chi X, Zhang R, Zhao T, Gong X, Wei R, Yin Z, Lin H, Li D, Shan H, Gao J (2019) Targeted arsenite-loaded magnetic multifunctional nanoparticles for treatment of hepatocellular carcinoma. Nanotechnology 17:175101
Cui Y, Xu Q, Chow PK, Wang D, Wang CH (2013) Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 33:8511–8520
Datt A, El-Maazawi I, Larsen SC (2012) Aspirin loading and release from MCM-41 functionalized with aminopropyl groups via co-condensation or postsynthesis modification methods. J Phys Chem C 34:18358–18366
Deng Z, Zhen Z, Hu X, Wu S, Xu Z, Chu PK (2011) Hollow chitosan–silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 21:4976–4986
Derfus AM, Chan WC, Bhatia SN (2004) Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 1:11–18
Duo Y, Yang M, Du Z, Feng C, Xing C, Wu Y, Xie Z, Zhang F, Huang L, Zeng X, Chen H (2018) CX-5461-loaded nucleolus-targeting nanoplatform for cancer therapy through induction of pro-death autophagy. Acta Biomater 79:317–330
Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J (2013) The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine 1:1–4
Fang IJ, Slowing II, Wu KC, Lin VS, Trewyn BG (2012) Ligand conformation dictates membrane and endosomal trafficking of arginine-glycine-aspartate (RGD)-functionalized mesoporous silica nanoparticles. Chemistry–a. European Journal 25:7787–7792
Gai F, Zhou T, Chu G, Li Y, Liu Y, Huo Q, Akhtar F (2016) Mixed anionic surfactant-templated mesoporous silica nanoparticles for fluorescence detection of Fe 3+. Dalton Trans 2:508–514
Gan Q, Lu X, Yuan Y, Qian J, Zhou H, Lu X, Shi J, Liu C (2011) A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica. Biomaterials 7:1932–1942
Gauro R, Nandave M, Jain VK, Jain K (2021) Advances in dendrimer-mediated targeted drug delivery to the brain. J Nanopart Res 23:76. https://doi.org/10.1007/s11051-021-05175-8
Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci 33:11613–11618
Han P, Ma N, Ren H, Xu H, Li Z, Wang Z, Zhang X (2010) Oxidation-responsive micelles based on a selenium-containing polymeric superamphiphile. Langmuir 18:14414–14418
Hanafi-Bojd MY, Jaafari MR, Ramezanian N, Xue M, Amin M, Shahtahmassebi N, Malaekeh-Nikouei B (2015) Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Eur J Pharm Biopharm 89:248–258
Haynes T, Bougnouch O, Dubois V, Hermans S (2020) Preparation of mesoporous silica nanocapsules with a high specific surface area by hard and soft dual templating approach: application to biomass valorization catalysis. Microporous Mesoporous Mater 306:110400
He Q, Ma M, Wei C, Shi J (2012a) Mesoporous carbon@ silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging. Biomaterials 17:4392–4402
He X, Zhao Y, He D, Wang K, Xu F, Tang J (2012b) ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles. Langmuir 35:12909–12915
Heggannavar GB, Hiremath CG, Achari DD, Pangarkar VG, Kariduraganavar MY (2018) Development of doxorubicin-loaded magnetic silica–pluronic F-127 nanocarriers conjugated with transferrin for treating glioblastoma across the blood–brain barrier using an in vitro model. ACS omega 7:8017–8026
Hoffmann F, Cornelius M, Morell J, Fröba M (2006) Silica-based mesoporous organic–inorganic hybrid materials. Angew Chem Int Ed 20:3216–3251
Horcajada P, Ramila A, Perez-Pariente J, Vallet-Regı M (2004) Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater 1-3:105–109
Huang X, Teng X, Chen D, Tang F, He J (2010) The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 3:438–448
Huang X, Zhang F, Lee S, Swierczewska M, Kiesewetter DO, Lang L, Zhang G, Zhu L, Gao H, Choi HS, Niu G (2012) Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials 17:4370–4378
Izquierdo-Barba I, Martinez Á, Doadrio AL, Pérez-Pariente J, Vallet-Regí M (2005) Release evaluation of drugs from ordered three-dimensional silica structures. Eur J Pharm Sci 5:365–373
Jain K, Gupta U, Jain NK (2014) Dendronized nanoconjugates of lysine and folate for treatment of cancer. Eur J Pharm Biopharm 87(3):500–509. https://doi.org/10.1016/j.ejpb.2014.03.015
Jokerst JV, Lobovkina T, Zare RN, Gambhir SS (2011) Nanoparticle PEGylation for imaging and therapy. Nanomedicine 4:715–728
Kaneda M, Tsubakiyama T, Carlsson A, Sakamoto Y, Ohsuna T, Terasaki O, Joo SH, Ryoo R (2002) Structural study of mesoporous MCM-48 and carbon networks synthesized in the spaces of MCM-48 by electron crystallography. J Phys Chem B 6:1256–1266
Khan MA, Jain VK, Rizwanullah M, Ahmad J, Jain K (2019) PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges. Drug Discov Today 24(11):2181–2191. https://doi.org/10.1016/j.drudis.2019.09.001
Kim KS, Kim J, Kim DH, Hwang HS, Na K (2018) Multifunctional trastuzumab–chlorin e6 conjugate for the treatment of HER2-positive human breast cancer. Biomater Sci 5:1217–1226
Kresge AC, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS (1992) Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 6397:710–712
Kumar B, Kulanthaivel S, Mondal A, Mishra S, Banerjee B, Bhaumik A, Banerjee I, Giri S (2017) Mesoporous silica nanoparticle-based enzyme responsive system for colon specific drug delivery through guar gum capping. Colloids Surf B: Biointerfaces 150:352–361
Kumar R, Roy I, Ohulchanskyy TY, Goswami LN, Bonoiu AC, Bergey EJ, Tramposch KM, Maitra A, Prasad PN (2008) Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 3:449–456
Kuppusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, Mitchell JB (2002) Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 1:307–312
Li H, Yan W, Suo X, Peng H, Yang X, Li Z, Zhang J, Liu D (2019) Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy. Biomaterials 200:1–4
Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JII (2012) Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 7:2590–2605
Liberman A, Martinez HP, Ta CN, Barback CV, Mattrey RF, Kono Y, Blair SL, Trogler WC, Kummel AC, Wu Z (2012) Hollow silica and silica-boron nano/microparticles for contrast-enhanced ultrasound to detect small tumors. Biomaterials 20:5124–5129
Lim MH, Stein A (1999) Comparative studies of grafting and direct syntheses of inorganic− organic hybrid mesoporous materials. Chem Mater 11:3285–3295
Lin YS, Haynes CL (2010) Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 13:4834–4842
Liu CM, Chen GB, Chen HH, Zhang JB, Li HZ, Sheng MX, Weng WB, Guo SM (2019) Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Colloids Surf B: Biointerfaces 175:477–486
Liu J, Huang Y, Kumar A, Tan A, Jin S, Mozhi A, Liang XJ (2014) pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv 4:693–710
Liu Y, Yang G, Jin S, Xu L, Zhao CX (2020) Development of High-Drug-Loading Nanoparticles ChemPlusChem 85:2143–2157
Liu Z, Tao Z, Zhang Q, Wan S, Zhang F, Zhang Y, Wu G, Wang J (2018) YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells. Cancer Chemother Pharmacol 4:687–695
López T, Basaldella EI, Ojeda ML, Manjarrez J, Alexander-Katz R (2006) Encapsulation of valproic acid and sodic phenytoin in ordered mesoporous SiO2 solids for the treatment of temporal lobe epilepsy. Opt Mater 1:75–81
Lou XW, Archer LA, Yang Z (2008) Hollow micro−/nanostructures: synthesis and applications. Adv Mater 21:3987–4019
Meenakshi Upreti AJ, Sethi P (2013) Tumor microenvironment and nanotherapeutics. Transl Cancer Res 4:309–319
Mehrasa M, Asadollahi MA, Nasri-Nasrabadi B, Ghaedi K, Salehi H, Dolatshahi-Pirouz A, Arpanaei A (2016) Incorporation of mesoporous silica nanoparticles into random electrospun PLGA and PLGA/gelatin nanofibrous scaffolds enhances mechanical and cell proliferation properties. Mater Sci Eng C 66:25–32
Meng F, Cheng R, Deng C, Zhong Z (2012) Intracellular drug release nanosystems Materials today 10:436–442
Mo J, He L, Ma B, Chen T (2016) Tailoring particle size of mesoporous silica nanosystem to antagonize glioblastoma and overcome blood–brain barrier. ACS Appl Mater Interfaces 11:6811–6825
Mo R, Jiang T, DiSanto R, Tai W, Gu Z (2014) ATP-triggered anticancer drug delivery Nature communications 1:1–10
Mozafarinia M, Karimi S, Farrokhnia M, Esfandiari J (2021) In vitro breast cancer targeting using Trastuzumab-conjugated mesoporous silica nanoparticles: towards the new strategy for decreasing size and high drug loading capacity for drug delivery purposes in MSN synthesis. Microporous Mesoporous Mater 316:110950
Narayan R, Gadag S, Cheruku SP, Raichur AM, Day CM, Garg S, Manandhar S, Pai KS, Suresh A, Mehta CH, Nayak Y (2021) Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: a smart pH-responsive and receptor-targeted system for colorectal cancer therapy. Carbohydr Polym 261:117893
Narayan R, Nayak UY, Raichur AM, Garg S (2018) Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics 3:118
Natarajan SK, Selvaraj S (2014) Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery. RSC Adv 28:14328–14334
Newalkar BL, Komarneni S, Katsuki H (2000) Rapid synthesis of mesoporous SBA-15 molecular sieve by a microwave–hydrothermal process. Chem Commun 23:2389–2390
Niesz K, Yang P, Somorjai GA (2005) Sol-gel synthesis of ordered mesoporous alumina. Chem Commun 15:1986–1987
Nozawa K, Gailhanou H, Raison L, Panizza P, Ushiki H, Sellier E, Delville JP, Delville MH (2005) Smart control of monodisperse Stöber silica particles: effect of reactant addition rate on growth process. Langmuir 4:1516–1523
Otsuka M, Tokumitsu K, Matsuda Y (2000) Solid dosage form preparations from oily medicines and their drug release. Effect of degree of surface-modification of silica gel on the drug release from phytonadione-loaded silica gels. J Control Release 2-3:369–384
Pal N, Bhaumik A (2013) Soft templating strategies for the synthesis of mesoporous materials: inorganic, organic–inorganic hybrid and purely organic solids. Adv Colloid Interf Sci 189:21–41
Pan G, Jia TT, Huang QX, Qiu YY, Xu J, Yin PH, Liu T (2017) Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-fluorouracil for the treatment of colon cancer with improved anticancer efficacy. Colloids Surf B: Biointerfaces 159:375–385
Qiu K, He C, Feng W, Wang W, Zhou X, Yin Z, Chen L, Wang H, Mo X (2013) Doxorubicin-loaded electrospun poly (L-lactic acid)/mesoporous silica nanoparticles composite nanofibers for potential postsurgical cancer treatment. J Mater Chem B 36:4601–4611
Roy I, Kumar P, Kumar R, Ohulchanskyy TY, Yong KT, Prasad PN (2014) Ormosil nanoparticles as a sustained-release drug delivery vehicle. RSC Adv 96:53498–53504
Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN (2003) Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug− carrier system for photodynamic therapy. J Am Chem Soc 26:7860–7865
Roy I, Stachowiak MK, Bergey EJ (2008) Nonviral gene transfection nanoparticles: function and applications in the brain. Nanomedicine: nanotechnology. Biol Med 2:89–97
Sakamoto Y, Kaneda M, Terasaki O, Zhao DY, Kim JM, Stucky G, Shin HJ, Ryoo R (2000) Direct imaging of the pores and cages of three-dimensional mesoporous materials. Nature 6811:449–453
Sánchez T, Salagre P, Cesteros Y (2013) Ultrasounds and microwave-assisted synthesis of mesoporous hectorites. Microporous Mesoporous Mater 171:24–34
Schmidt HK, Geiter E, Mennig M, Krug H, Becker C, Winkler RP (1998) The sol-gel process for nano-technologies: new nanocomposites with interesting optical and mechanical properties. J Sol-Gel Sci Technol 1:397–404
Sharma KK, Asefa T (2007) Efficient bifunctional nanocatalysts by simple postgrafting of spatially isolated catalytic groups on mesoporous materials. Angewandte Chemie International EditionApr 16:2879–2882
Slowing I, Trewyn BG, Lin VS (2006) Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 46:14792–14793
Slowing II, Vivero-Escoto JL, Wu CW, Lin VS (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 11:1278–1288
Song JT, Yang XQ, Zhang XS, Yan DM, Wang ZY, Zhao YD (2015) Facile synthesis of gold nanospheres modified by positively charged mesoporous silica, loaded with near-infrared fluorescent dye, for in vivo X-ray computed tomography and fluorescence dual mode imaging. ACS Appl Mater Interfaces 31:17287–17297
Song SW, Hidajat K, Kawi S (2005) Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix− drug interactions. Langmuir 21:9568–9575
Soni N, Jain K, Gupta U, Jain NK (2015) Controlled delivery of gemcitabine hydrochloride using mannosylated poly(propyleneimine) dendrimers. J Nanopart Res 17:458. https://doi.org/10.1007/s11051-015-3265-1
Soto RJ, Yang L, Schoenfisch MH (2016) Functionalized mesoporous silica via an aminosilane surfactant ion exchange reaction: controlled scaffold design and nitric oxide release. ACS Appl Mater Interfaces 3:2220–2231
Suthar T, Navneet, Jain K (2021) Nutraceuticals against neurodegeneration: understanding the mechanistic pathways. In: Lokhande JN, Pathak YV (eds) Nutraceuticals for aging and anti-aging: basic understanding and clinical evidence. CRC Press, ISBN: 9781003110866; pp 133–168
Suthar T, Jain VK, Popli H, Jain K (2022) 12 - Nanoemulsions as effective carriers for targeting brain tumors. In: Kumar L, Pathak Y (eds) Nanocarriers for drug-targeting brain tumors. Elsevier, pp 347–363 https://doi.org/10.1016/B978-0-323-90773-6.00008-7
Suthar T, Patel P, Singh P, Datusalia AK, Yadav AK, Jain K (2023) Hesperidin microemulsion: Formulation optimization, characterization, and in vitro evaluation. J Drug Del Sci Tech 80(104166):1–12
Taratula O, Garbuzenko OB, Chen AM, Minko T (2011) Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J Drug Target 10:900–914
Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 7:579–591
Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS (2010) Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 18:1952–1967
Wang G, Otuonye AN, Blair EA, Denton K, Tao Z, Asefa T (2009) Functionalized mesoporous materials for adsorption and release of different drug molecules: a comparative study. Journal of Solid-State Chemistry 7:1649–1660
Wang Q, Hu W, Cai L, Huang Y, Qian Z (2017) Nanomedicines in bone cancer—from diagnostics to therapies. J Biomed Nanotechnol 8:911–930
Wang Y, Han N, Zhao Q, Bai L, Li J, Jiang T, Wang S (2015) Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers. Eur J Pharm Sci 72:12–20
Wanka G, Hoffmann H, Ulbricht W (1994) Phase diagrams and aggregation behavior of poly (oxyethylene)-poly (oxypropylene)-poly (oxyethylene) triblock copolymers in aqueous solutions. Macromolecules 15:4145–4159
Watermann A, Brieger J (2017) Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nano 7:189
Xie X, Li F, Zhang H, Lu Y, Lian S, Lin H, Gao Y, Jia L (2016) EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Eur J Pharm Sci 83:28–35
Xiong L, Yang T, Yang Y, Xu C, Li F (2010) Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 27:7078–7085
Yamada H, Urata C, Higashitamori S, Aoyama Y, Yamauchi Y, Kuroda K (2014) Critical roles of cationic surfactants in the preparation of colloidal mesostructured silica nanoparticles: control of mesostructure, particle size, and dispersion. ACS Appl Mater Interfaces 5:3491–3500
Yang KN, Zhang CQ, Wang W, Wang PC, Zhou JP, Liang XJ (2014) pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment. Cancer Biol Med 1:34–43
Yang L, Yin T, Liu Y, Sun J, Zhou Y, Liu J (2016b) Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer’s disease treatment. Acta Biomater 46:177–190
Yang P, Zhao D, Margolese DI, Chmelka BF, Stucky GD (1999) Block copolymer templating syntheses of mesoporous metal oxides with large ordering lengths and semicrystalline framework. Chem Mater 10:2813–2826
Yang Y, Achazi K, Jia Y, Wei Q, Haag R, Li J (2016a) Complex assembly of polymer conjugated mesoporous silica nanoparticles for intracellular pH-responsive drug delivery. Langmuirm 47:12453–12460
You Y, Yang L, He L, Chen T (2016) Tailored mesoporous silica nanosystem with enhanced permeability of the blood–brain barrier to antagonize glioblastoma. J Mater Chem B 36:5980–5990
You YZ, Kalebaila KK, Brock SL, Oupicky D (2008) Temperature-controlled uptake and release in PNIPAM-modified porous silica nanoparticles. Chem Mater 10:3354–3359
Zhang B, Luo Z, Liu J, Ding X, Li J, Cai K (2014b) Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo. J Control Release 192:192–201
Zhang L, Li Y, Jimmy CY, Chen YY, Chan KM (2014a) Assembly of polyethylenimine-functionalized iron oxide nanoparticles as agents for DNA transfection with magnetofection technique. J Mater Chem B 45:7936–7944
Zhao D, Feng J, Huo Q, Melosh N, Fredrickson GH, Chmelka BF, Stucky GD (1998a) Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 5350:548–552
Zhao D, Huo Q, Feng J, Chmelka BF, Stucky GD (1998b) Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc 24:6024–6036
Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H (2018) TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Mater Sci Eng C 84:108–117
Zhuang J, Zhou L, Tang W, Ma T, Li H, Wang X, Chen C, Wang P (2021) Tumor targeting antibody-conjugated nanocarrier with pH/thermo dual-responsive macromolecular film layer for enhanced cancer chemotherapy. Mater Sci Eng C 118:111361
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ramteke, U., Kumar, V., Batheja, S., Phulmogare, G., Gupta, U. (2023). Functionalized Mesoporous Silica-Based Nanoparticles for Theranostic Applications. In: Jain, K., Jain, N.K. (eds) Multifunctional And Targeted Theranostic Nanomedicines. Springer, Singapore. https://doi.org/10.1007/978-981-99-0538-6_16
Download citation
DOI: https://doi.org/10.1007/978-981-99-0538-6_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-0537-9
Online ISBN: 978-981-99-0538-6
eBook Packages: MedicineMedicine (R0)